Omada Health, Inc.
OMDAHealthcareNASDAQHealth Information Services · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Omada Health, Inc. focuses on Health Information Services services and products. Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. With a market capitalization of $1.16B, it sits in small-cap territory. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Market Cap
$1.16B
Beta
—
P/E (TTM)
78.96
P/E (Fwd)
34.07
EPS (TTM)
$0.24
EPS (Fwd)
$0.56
ROE
1.8%
ROA
-0.1%
Cash
$221.7M
Total Debt
$0
Free CF
$11.9M
52W Change
-28.3%
Annual Financials
Cash vs Debt
Where OMDA stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, OMDA finished 5.77% below its 150-day moving average ($18.71) and 0.63% above its 200-day moving average ($17.52). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is OMDA overbought or oversold?
At the October 19, 2026 close, OMDA's RSI(14) was 40.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Omada Health, Inc. reports $221.7M in cash and $0 in total debt. Annual free cash flow of $11.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 1.8%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $89.2M (2022) to $260.2M (2025), reflecting a 192% increase over the period.
At over 50x earnings, OMDA carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Omada Health, Inc.'s trajectory.